BPC-157 / TB-500 10mg/10mg Blend is a research-grade combination peptide formulation containing 10mg BPC-157 (Body Protection Compound-157) and 10mg TB-500 (synthetic fragment of Thymosin Beta-4) per vial (total 20mg lyophilized powder). This blend is designed for laboratory studies exploring synergistic effects on tissue repair mechanisms, where the two peptides are frequently investigated together due to their complementary pathways in preclinical models. BPC-157 is a synthetic, stable pentadecapeptide (15 amino acids) with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (molecular weight ≈1419.55 Da), derived from a protective protein fragment in human gastric juice. It exhibits notable stability in acidic environments and resistance to enzymatic degradation, making it suitable for investigations into cytoprotection, angiogenesis, growth factor signaling, anti-inflammatory modulation, and tissue regeneration in various organ and musculoskeletal models. TB-500 is a synthetic, acetylated fragment (typically the active N-terminal domain Ac-LKKTETQ or extended forms) of the naturally occurring 43-amino-acid Thymosin Beta-4 protein (full Tβ4 sequence: SDKPDMAEI EKFDKSKLKK TETQEKNPLP SKETIEQEKQ AGES; full MW ≈4963 Da; fragment often studied at ≈889–4963 Da depending on exact variant). It is researched for its role in actin sequestration and regulation, promoting cell migration, differentiation, extracellular matrix remodeling, angiogenesis, and wound healing dynamics in cellular and animal models. In combination, this blend is commonly utilized in in vitro and preclinical laboratory research to examine potential synergistic interactions, such as enhanced cellular migration and proliferation, improved vascular support, accelerated soft tissue (muscle, tendon, ligament) repair pathways, inflammation modulation, and overall regenerative signaling in musculoskeletal, gastrointestinal, neurological, and wound-healing models. Studies suggest complementary mechanisms: BPC-157 supporting nitric oxide pathways, growth factor receptor expression, and cytoprotective effects, while TB-500 facilitates actin dynamics and migratory processes for more comprehensive tissue remodeling. Supplied as high-purity lyophilized powder (>98% purity, verified by HPLC and mass spectrometry), the BPC-157 / TB-500 blend is intended exclusively for in vitro research and scientific experimentation by qualified professionals.
BPC157/TB500 10mg/10mg
Price range: $100.00 through $650.00
BPC-157 / TB-500 10mg/10mg Blend is a research-grade combination peptide formulation containing 10mg BPC-157 (Body Protection Compound-157) and 10mg TB-500 (synthetic fragment of Thymosin Beta-4) per vial (total 20mg lyophilized powder).
Views More
Critical Compliance Notice – For Research Use Only
This product is sold strictly for in vitro laboratory research and scientific experimentation by qualified professionals. It is not approved by the FDA or any regulatory agency for human consumption, medical treatment, diagnostic use, veterinary application, food additive, cosmetic ingredient, or performance enhancement. It is not a drug, dietary supplement, or therapeutic agent. Any off-label or non-research use is strictly prohibited and may violate applicable federal, state, or local laws (including the Federal Food, Drug, and Cosmetic Act). By purchasing, the buyer acknowledges and agrees that the product will be used solely for lawful research purposes in a controlled laboratory setting. Handle with appropriate safety precautions; consult institutional guidelines and regulations.





Reviews
There are no reviews yet.